| GC46554-25mg |
|
36940-87-1 |
2’-O-Monosuccinyladenosine-3’,5’-cyclic monophosphate
|
0 |
C14H16N5O9P |
|
|
|
| GC46554-10mg |
|
36940-87-1 |
2’-O-Monosuccinyladenosine-3’,5’-cyclic monophosphate
|
0 |
C14H16N5O9P |
|
|
|
| GC46554-5mg |
|
36940-87-1 |
2’-O-Monosuccinyladenosine-3’,5’-cyclic monophosphate
|
0 |
C14H16N5O9P |
|
|
|
| GC46553-50mg |
|
55396-45-7 |
2-Nonylquinolin-4(1H)-one
|
0 |
C18H25NO |
|
|
|
| GC46553-25mg |
|
55396-45-7 |
2-Nonylquinolin-4(1H)-one
|
0 |
C18H25NO |
|
|
|
| GC46553-10mg |
|
55396-45-7 |
2-Nonylquinolin-4(1H)-one
|
0 |
C18H25NO |
|
|
|
| GC46553-5mg |
|
55396-45-7 |
2-Nonylquinolin-4(1H)-one
|
0 |
C18H25NO |
|
|
|
| GC46552-50mg |
|
— |
2-methyl-α-Pyrrolidinopropiophenone (hydrochloride)
|
0 |
C14H19NO.HCl |
|
|
|
| GC46552-10mg |
|
— |
2-methyl-α-Pyrrolidinopropiophenone (hydrochloride)
|
0 |
C14H19NO.HCl |
|
|
|
| GC46552-5mg |
|
— |
2-methyl-α-Pyrrolidinopropiophenone (hydrochloride)
|
0 |
C14H19NO.HCl |
|
|
|
| GC46551-5mg |
|
— |
2-Methylbutyryl-L-carnitine-d3 (chloride)
|
0 |
C12H21D3NO4.Cl |
|
|
|
| GC46551-1mg |
|
— |
2-Methylbutyryl-L-carnitine-d3 (chloride)
|
0 |
C12H21D3NO4.Cl |
|
|
|
| GC46551-500μg |
|
— |
2-Methylbutyryl-L-carnitine-d3 (chloride)
|
0 |
C12H21D3NO4.Cl |
|
|
|
| GC46550-5mg |
|
1080-95-1 |
|
0 |
C13H18N2 |
|
|
|
| GC46550-1mg |
|
1080-95-1 |
|
0 |
C13H18N2 |
|
|
|
| GC46549-250mg |
|
188783-78-0 |
|
0 |
C12H17FO7 |
|
|
|
| GC46549-100mg |
|
188783-78-0 |
|
0 |
C12H17FO7 |
|
|
|
| GC46549-50mg |
|
188783-78-0 |
|
0 |
C12H17FO7 |
|
|
|
| GC46548-5mg |
|
111982-45-7 |
2-Fluorophenyl Cyclopentyl Ketone
|
0 |
C12H13FO |
|
|
|
| GC46548-1mg |
|
111982-45-7 |
2-Fluorophenyl Cyclopentyl Ketone
|
0 |
C12H13FO |
|
|
|
